hepatitis C

New discovery may improve hepatitis C treatment

harminka — Wed, 23 Sep 2009 10:04:00 -0500

Walter and Eliza Hall Institute researchers are part of an international team that has discovered a genetic variation that could identify those people infected with hepatitis C who are most likely to benefit from current treatments.

HCV Protease Inhibitor Telaprevir Halves Treatment Time for Hepatitis C Patients

harminka — Fri, 05 Jun 2009 12:13:02 -0500

For patients with the most common form of hepatitis C, the addition of a hepatitis C–specific protease inhibitor called telaprevir to the current standard therapy can significantly improve the chances of being cured, and it does it in half the time of standard therapy alone.

Human genes required for hepatitis C viral replication

harminka — Wed, 18 Mar 2009 12:06:59 -0500

Massachusetts General Hospital (MGH) researchers are investigating a new way to block reproduction of the hepatitis C virus (HCV) – targeting not the virus itself but the human genes the virus exploits in its life cycle.

Transplanted fatty livers associated with bad prognosis for HCV patients

harminka — Wed, 14 Jan 2009 05:55:18 -0600

A new study suggests that patients with hepatitis C (HCV) who need a liver transplant should not receive an organ with high levels of fatty deposits (a.k.a. hepatic steatosis).

Hepatitis C may increase pancreatic cancer risk

harminka — Wed, 14 Jan 2009 04:22:02 -0600

A new study shows that infection with hepatitis C virus (HCV) increases a person’s risk for a highly fatal cancer of the biliary tree, the bile carrying pathway between the liver and pancreas.

Sixty Thousand Patients Placed Under Hepatitis Risk

Armen Hareyan — Thu, 08 Jan 2009 08:43:23 -0600

CDC reports that failures to follow infection practices have placed more than 60,000 patients at risk for Hepatitis B and C.

May hepatic granulomas be part of histological spectrum of chronic hepatitis C?

harminka — Mon, 29 Dec 2008 13:48:11 -0600

While older large series of patients with hepatic granulomas have found sarcoidosis and tuberculosis to be the most common causes of hepatic granulomas, recent works have noted some patients with chronic hepatic C and hepatic granulomas and no other obvious associations.

Weighing Hepatitis C virus hold on membranes

harminka — Mon, 20 Oct 2008 11:56:25 -0500

Hepatitis C affects around 150 million people worldwide and is a major cause of chronic liver disease. Current treatment involves the anti-viral drugs interferon and ribavirin, both of which have serious side effects.

Tibotec begins enrollment for Phase III study of telaprevir

harminka — Wed, 15 Oct 2008 11:34:35 -0500

REALIZE is the first phase III study to evaluate a specifically targeted antiviral therapy for hepatitis C (STAT-C) across a full range of HCV-patients who failed prior treatment to current standard of care, including null responders -

Liver damage in hepatitis C patients could be treated with warfarin

harminka — Fri, 01 Aug 2008 14:43:20 -0500

The drug warfarin may help prevent liver failure in thousands of people with Hepatitis C, according to new research.

Researchers disprove long-standing belief about HIV treatment

harminka — Fri, 25 Jul 2008 02:30:33 -0500

Researchers at Wake Forest University Baptist Medical Center have disproved a long-standing clinical belief that the hepatitis C virus slows or stunts the immune system's ability to restore itself after HIV patients are treated with a combination of drugs known as the "cocktail."

Natalie Cole Reveals Having Hepatitis C

Armen Hareyan — Wed, 16 Jul 2008 11:32:54 -0500

Natalie Cole, the 58-year-old Grammy award winning singer, has announced her diagnosis with hepatitis C.